Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

Given we have all the approvals that we can get this year (meaning as far as Nasrat has let us know there is nothing still pending, right?) our best bet for share price moving news is the launch of one of the following:
- Adderall IR in Isreal
- Generic Sabril
- Generic Doxycycline

All three have 'issues/complexities' that prevent them from being completed in a timely manner. I don't expect any of these to be launched before the end of the end of the summer and probably not before end of calendar year.

Share price could get ugly in the meantime unless we get a surprise deal/accomplishment dropped on us. Value of the company is still good but that doesn't matter on the OTC.

Anyone know of any other possible good news events? I am not that excited about Elite buying the other half of the Adderall license fees. I don't think Nasrat is going to give us a 'deal' on the price so I think our money is better invested in developing newer drugs rather than in a drug that is losing market share.